XT
VYGR icon

XTX Topco’s Voyager Therapeutics VYGR Stock Holding History

XTX Topco’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+32,058
New +$122K ﹤0.01% 3494
2026
Q1 		– Sell
-14,417
Closed -$56.7K – 4449
2025
Q4 		$56.7K Sell
14,417
-8,585
-37% -$38K ﹤0.01% 2798
2025
Q3 		$107K Buy
+23,002
New +$83.2K 0.01% 2012
2025
Q2 		– Sell
-16,172
Closed -$54.7K – 3245
2025
Q1 		$54.7K Sell
16,172
-15,203
-48% -$71K ﹤0.01% 1988
2024
Q4 		$178K Buy
+31,375
New +$202K 0.01% 1597
2024
Q2 		– Sell
-24,029
Closed -$224K – 2523
2024
Q1 		$224K Sell
24,029
-486
-2% -$4.1K 0.03% 1083
2023
Q4 		$207K Buy
+24,515
New +$178K 0.05% 937
2022
Q4 		– Sell
-28,718
Closed -$170K – 1546
2022
Q3 		$170K Buy
28,718
+3,193
+13% +$20.4K 0.04% 834
2022
Q2 		$151K Buy
+25,525
New +$172K 0.06% 540
2021
Q3 		– Sell
-33,510
Closed -$138K – 1090
2021
Q2 		$138K Buy
33,510
+5,306
+19% +$24K 0.05% 619
2021
Q1 		$133K Buy
+28,204
New +$192K 0.06% 543

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

XTX Topco's VYGR Position: Q2 2026 in Review

XTX Topco opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 32,058 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #3494 among its holdings. This is a return to the name: XTX Topco previously reported a position in VYGR as recently as Q4 2025.

XTX Topco first reported a position in VYGR in Q1 2021 and has held it in 11 quarters since. The position peaked at $224K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • XTX Topco held 32,058 shares of Voyager Therapeutics worth $112K as of Q2 2026.
  • Voyager Therapeutics was a new XTX Topco position in Q2 2026.
  • Voyager Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3494 holding.
  • XTX Topco first reported a position in Voyager Therapeutics in Q1 2021 and has held it in 11 quarters since.
  • XTX Topco's Voyager Therapeutics position peaked at $224K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.